Concepedia

Kristen L. Weber-Bonk

KL

Statistics

Publications

7

Citations

316

H-Index

7

Active since

2016

Affiliations

Case Western Reserve University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The Ohio State University

Kristen L. Weber-Bonk is an author at Case Western Reserve University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2016–2020

7

Publications

7

Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells

Sylvia S. Gayle, Jennifer M. Sahni, Bryan M. Webb et al. · Journal of Biological Chemistry · 2018 · 59 citations · Full text

, , +12

Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases

Jennifer M. Sahni, Sylvia S. Gayle, Kristen L. Weber-Bonk et al. · Journal of Biological Chemistry · 2016 · 56 citations · Full text

, , +15

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer

Darcie D. Seachrist, Steven T. Sizemore, Emhonta Johnson et al. · Breast Cancer Research · 2017 · 50 citations · Full text

, , +17

The transcriptional repressor BCL11A promotes breast cancer metastasis

Darcie D. Seachrist, Molly M. Hannigan, Natasha N. Ingles et al. · Journal of Biological Chemistry · 2020 · 49 citations · Full text

, , +17

LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance

Melyssa S. Roberts, Jennifer M. Sahni, Morgan S. Schrock et al. · Cancer Research · 2020 · 38 citations · Full text

, , +17

1–5 of 7